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Phosphoinositide-dependent kinase 1 (PDK1) is at the
hub of many signalling pathways, activating PKB and
PKC isoenzymes, as well as p70 S6 kinase and perhaps
PKA. PDK1 action is determined by colocalization with
substrate and by target site availability, features that may
enable it to operate in both resting and stimulated cells.
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Phosphorylation is probably the most general mechanism
of protein regulation, and is most often effected by the
activation of protein kinases. These ubiquitous enzymes
are classified in part by the nature of their target residue:
serine/threonine (dual specificity here being the rule),
tyrosine or, more rarely, histidine. Two mechanisms of
protein kinase activation are most commonly encountered,
often operating sequentially. One involves displacement
of an inhibitory domain or subunit from the kinase cat-
alytic domain, to which it is bound through a ‘pseudosub-
strate’ motif [1]. Displacement is variously achieved, for
example by binding of a small ligand, such as cAMP or
diacylglycerol (DAG), or polypeptide, such as the calmod-
ulin–calcium complex, to a region adjacent to, or overlap-
ping with, the inhibitory domain, or occasionally by
phosphorylation of the inhibitory domain. 
The other common mechanism of kinase activation is by
phosphorylation at a site within the catalytic domain. The
catalytic domains of many kinases share certain conserved
features, allowing a common structural description. For
these kinases, the activating phosphorylation occurs at
serine/threonine or tyrosine residues situated in
subdomain VIII, between the conserved tripeptide
sequences — DFG and APE in the single-letter amino-
acid code — a segment that has come to be known as the
‘activation’ loop [2]. Progress in understanding the role
activation loop phosphorylation plays in the regulation of
the important ‘AGC’ kinases has accelerated recently, fol-
lowing the discovery that the phosphoinositide-dependent
protein kinases, or PDKs, are the activation loop kinases
for enzymes of the protein kinase B (PKB) subclass [3,4].
The AGC class of kinases phosphorylate their targets on
serine or threonine residues, and include some of the most
familiar regulatory enzymes, which have key roles on a
number of important intracellular signalling pathways.
They include the cAMP-regulated protein kinase A (PKA),
the various isoforms of protein kinase C (PKC), the PKBs,
p70 S6 kinase and the ribosomal S6 kinases (RSKs). These
kinases are evolutionarily related [5], their catalytic domains
showing roughly 40% sequence identity (Figure 1). Each of
these kinases requires activation loop phosphorylation to
achieve catalytic competence, but the role of this phospho-
rylation in the kinase life cycle and its regulation — if any
— varies significantly from enzyme to enzyme.
The PKBs, for example, are rapidly activated in vivo by
receptor tyrosine kinases, acting via a phosphatidylinositol
3-kinase (PI 3-kinase)-dependent pathway [6]. PKBs have
a carboxy-terminal catalytic domain and an amino-termi-
nal, non-catalytic segment that contains a pleckstrin
homology (PH) domain, through which they can bind
directly and selectively to phosphatidylinositol (3,4) bis-
phosphate (PIP2) and phosphatidylinositol (3,4,5) trisphos-
phate (PIP3). Receptor tyrosine kinase activation of PKB
in vivo, however, requires PKB phosphorylation at two
sites, serine 308 in the activation loop and threonine 473
near the carboxyl terminus [7]. A protein kinase capable of
phosphorylating PKB in vitro selectively at serine 308, in a
reaction completely dependent on added PIP3, was identi-
fied a year or so ago [8] and named phosphatidylinositol 3-
phosphate-dependent kinase-1 (PDK1). The hypothetical
kinase responsible for threonine 473 phosphorylation,
usually called PDK2, remains unidentified. 
PDK1 is a 556 amino-acid protein with an amino-terminal
catalytic domain in AGC class and a non-catalytic carboxy-
terminal tail containing a PH domain. Recombinant PDK1
phosphorylates PKB serine 308 directly, in a reaction that
is almost completely dependent on PIP3. The major effect
of PIP3 — in addition to directing colocalization of
enzyme and substrate by bringing both to the plasma
membrane — is exerted on the substrate, rather than by a
direct activation of PDK1’s catalytic activity. Thus,
binding of PKB to PIP3 induces a conformational change
that increases the accessibility of PKB’s target serine to
PDK1. Consistent with this conclusion, PIP3 stimulation
of the phosphorylation reaction is lost on deletion of
PKB’s PH domain, but not of PDK1’s PH domain. More-
over, the activity of recombinant PDK1 expressed in
mammalian cells is unaffected by stimuli that strongly
activate PKB through PI-3 kinase [3].
The discovery of PDK1 as (one of) the kinases responsi-
ble for the PIP3-dependent phosphorylation of PKB’s
activation loop immediately raised the possibility that
PDK1 might also act on other protein kinases previously
shown to be activated downstream of PI-3 kinase, espe-
cially the p70 S6 kinase and atypical PKCs λ/ι and ξ.
Indeed, PDK1 phosphorylates p70 in vitro [9,10] selec-
tively in the activation loop in a PIP3-independent
manner, at a rate comparable to that observed for PKB
serine 308 in the presence of PIP3 [9]. Phosphorylation of
p70 by PDK1 is probably regulated in vivo by the accessi-
bility of the p70 activation loop, which is controlled by
multiple, proline-directed phosphorylations within an
autoinhibitory pseudosubstrate domain in the carboxy-
terminal tail and by phosphorylation of threonine 412, the
equivalent of PKB’s threonine 473 [9,11].
The so-called ‘atypical’ PKCs λ/ι and ξ, which are insensi-
tive to the phorbol ester TPA, show a modest activation
after receptor tyrosine kinase stimulation which appears to
be PI 3-kinase-dependent. Although these PKCs lack PH
domains, they probably do interact with PIP3, as it is one of
the phospholipids capable of supporting their maximal
activity in vitro. A number of observations indicate that the
PI 3-kinase-dependent activation of these PKCs is medi-
ated by PDK1. Thus, PDK1 and PKCξ associate in vivo
via their catalytic domains, and coexpression with PDK1
enhances PKCξ activity and activation-loop phosphoryla-
tion in a manner sensitive to the PI 3-kinase inhibitor
wortmannin [12,13]. The wortmannin-sensitivity of the
reaction is unaffected by deletion of the non-catalytic part
of PKCξ, but is abolished by deletion of PDK1’s PH
domain [12]. Moreover, receptor tyrosine kinase stimula-
tion of PKCξ is prevented by a kinase-negative PDK1
[12,13]. In vitro, PDK1 catalyzes direct phosphorylation of
the PKCξ activation loop, accompanied by a six-fold
increase in PKCξ’s kinase activity. PDK1 thus appears to
be a strong candidate for being a PI 3-kinase-controlled
activator of PKCξ. The major uncertainty about PKCξ
activation concerns the possible existence and identity of
the other controlling inputs.
The role of PDK1 in activation of PKCδ, which is consid-
ered a ‘novel’ isoform as it is TPA responsive but calcium-
independent, is less certain. Although PDK1 associates
with PKCδ in vivo and directly phosphorylates the activa-
tion loop of PKCδ in vitro, the latter reaction occurs at a
rate only 2–3-fold greater than autophosphorylation of the
PKCδ activation loop. Phosphorylation of PKCδ by PDK1
is stimulated 2-fold by PIP3 and 3.7-fold when both PIP3
and TPA are present [12], but the physiological signifi-
cance of this very weak PDK1-catalyzed phosphorylation
of the PKCδ activation loop is uncertain, in as much as
mutation of the relevant PKCδ residue (threonine 505)
does not interfere with TPA activation of the enzyme in
vivo or in vitro [14].
The ‘conventional’ PKC isoforms — α, βI, βII and γ —
are all subject to activation loop phosphorylation in vivo
[15]. It is not known whether this phosphorylation is 
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Figure 1
Sequence alignment of several
serine/threonine kinases from the AGC class,
in the segment of catalytic subdomain VIII
known as the activation loop. (a) These seven
enzymes have been shown to be substrates
for PDK1. The threonine phosphorylated by
PDK1 is indicated by arrow heads; identical
residues are in bold and highlighted in the
yellow boxes. A possible consensus motif is
depicted; φ denotes a hydrophobic residue.
(b) PKCλ/ι, PKCε and PRK1 are predicted to
be targets of PDK1, based on sequence
conservation and the ability of PIP3 to stimulate
their activation loop phosphorylation in vivo or
in vitro. (c) PKG and RSK (p90R6K) are AGC
family kinases that have similar activation loop
sequences and are known to undergo
activation loop phosphorylation in vivo.
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regulated in response to extracellular stimuli, such as
growth factors, but dephosphorylation at this site in vitro
does not alter the kinases’ ability to be activated by Ca2+
and DAG. But mutation of the activation loop phosphory-
lation sites does abolish the ability of these PKCs to gain
catalytic competence, and the mutant polypeptides are
found in insoluble aggregates. 
The catalytic competence of a mature conventional PKC
depends on phosphorylation at two sites near the protein’s
carboxyl terminus, in a 65–70 amino-acid segment that
immediately follows the catalytic domain. This segment is
highly conserved in sequence and location among all PKC
isoforms, and is also present in the PKBs, p70 S6 kinase
and the RSK amino-terminal domain; it is, however, absent
in the PKAs. Phosphorylation of these carboxy-terminal
sites in the conventional PKCs is catalyzed by intramolecu-
lar autophosphorylation, which can happen only after acti-
vation loop phosphorylation by another kinase — which, as
explained below, is likely to be PDK1. Once the carboxy-
terminal sites have been phosphorylated, the activation
loop phosphorylation is dispensable [15].
PDK1 can phosphorylate the activation loop site of
PKCβII in vitro. Phosphorylation of mature PKCβII by
PDK1 does not alter its activity, but phosphorylation of
the completely unphosphorylated protein triggers the
carboxy-terminal autophosphorylation reactions, recapitu-
lating the sequence of PKCβII maturation in vivo. Fur-
thermore, coexpression of PKCβII with a kinase-inactive
mutant form PDK1 leads to the accumulation of unphos-
phorylated and inactive PKCβII [16]. PDK1 — or an
enzyme of very similar specificity — is thus likely to be
the kinase response for the constitutive, early phosphory-
lation of the activation loop in PKCβII, and probably also
in the other conventional PKCs.
The constitutive phosphorylation of the PKA phosphory-
lation loop (on threonine 197) can be catalyzed by
intermolecular autophosphorylation, as occurs, for
example, during expression of recombinant PKA in
bacterial cells. But there is considerable evidence that, in
mammalian cells, this phosphorylation is catalyzed by
another protein kinase [17]. Again, PDK1 is implicated: it
has been shown to be capable of efficiently phosphorylat-
ing recombinant catalytic subunit of PKA in vitro at threo-
nine 197 [18]. There is as yet no evidence that PDK1
mediates PKA phosphorylation in vivo, or any indication as
to how PDK1 is related to a previously described [17] PKA
(threonine 197) kinase.
PDK1’s ability to catalyze activation loop phosphorylation
for most of the AGC kinases raises several interesting
questions. Which of the other AGC kinases are also likely
to be PDK1 substrates? Clearly, any protein kinase previ-
ously observed to be regulated by PIP3, such as PKCε [19]
and PRK1 [20], is a likely substrate, as are other members
of the AGC family. PDK1 might also phosphorylate non-
kinase substrates, such as other proteins that are colocal-
ized with PDK1 by their shared affinity for PIP3 or even
constitutive membrane proteins. Although most activation
loop kinases, such as Raf or the mitogen activated protein
(MAP) kinase kinases, have narrow specificities, MAP
kinase itself is an activation loop kinase for both RSK and
Mnk, and also has many non-kinase substrates.
How many PDK-like kinases [4] are there? And are the
same or different members of the expected kinase family
responsible for the constitutive phosphorylation that occurs
in unstimulated cells — such as that of PKA on threonine
197 and PKCβII on threonine 500 — as well as the phos-
phorylation that occurs only after receptor-stimulated PI 3-
kinase activation? One might expect that reactions subject
to such different regulation would be catalyzed by differ-
ent kinases. But this may well be incorrect, given the
important role of activation loop accessibility, a property
controlled at the substrate level, in PDK1-catalyzed phos-
phorylation of PKB and p70 S6 kinase. If the intrinsic
activity of PDK1 is relatively high in unstimulated cells,
the constitutive phosphorylations (as of PKCβII and PKA)
might simply reflect substrates where access to the site of
phosphorylation is unimpeded (Figure 2). The stability of
this ‘basal’ activation loop phosphorylation, as compared to
the rapid turnover of stimulated activation loop phosphory-
lation, probably reflects the relative accessibility of these
sites, once phosphorylated, to protein phosphatases, as well
as the activity levels of the relevant phosphatases.
There is considerable interest in the issue of what
determines the substrate specificity of PDKs. The
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Figure 2
The various kinases suggested to be targets of PDK1 are shown.
Those phosphorylated primarily after cell stimulation — PKBs, p70 S6
kinase and the atypical PKCs — are at the top, whereas those that are
phosphorylated in unstimulated cells — the conventional PKCs and the
PKAs — are at the bottom. PDPKs, proline-directed protein kinases;
DAG, diacylglycerol; PIP3, phosphatidylinositol (3,4,5) trisphosphate.
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primary sequence surrounding the site of activation loop
phosphorylation is highly conserved among the various
candidate PDK1 substrates identified so far (Figure 2).
But synthetic peptides corresponding to these sequences
are very poorly phosphorylated by PDK1. Moreover,
mutation of the primary phosphorylation site in the PKCα
activation loop — threonine 497 — results in the phospho-
rylation of one or more of the nearby threonines (residues
494 or 495), and mutation of all three sites is required to
fully prevent PKCα activation loop phosphorylation [21].
The PKCα activation loop kinase (PDK1?) is thus rela-
tively relaxed in its selection of available phosphorylation
sites. The limited relevant information available for other
activation loop kinases — Raf, MAP kinase and so on —
indicates that a major determinant of specificity is likely to
be a protein–protein interaction site distinct from the acti-
vation loop itself. It seems likely that PDK1 substrates
will also turn out to have such kinase binding sites. Eluci-
dation of the molecular diversity and substrate specifici-
ties of PDKs is an important goal, one that will
undoubtedly be addressed in the near future.
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